FIBROPLATE INC
Las Vegas, NV · Biotech · Private
Fibrinogen-coated Albumin nano-Spheres (FAS) injectable therapeutic to accelerate bone fracture healing in elderly patients
fibroplate.com →- Grants
- $5.4M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A multivalent, easy-to-use product to mitigate and treat radiation exposure | $180,536 | |
| Federal grant | Department of Health and Human Services · Phase I · A multivalent, easy-to-use product to mitigate and treat radiation exposure | $180,536 | |
| Federal grant | Department of Health and Human Services · Phase II · A multivalent, easy-to-use product to mitigate and treat radiation exposure | $933,782 | |
| Federal grant | Department of Health and Human Services · Phase II · A multivalent, easy-to-use product to mitigate and treat radiation exposure | $1,811,658 | |
| Federal grant | Department of Health and Human Services · Phase II · A multivalent, easy-to-use product to mitigate and treat radiation exposure | $877,876 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness | $253,688 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness | $253,688 | |
| Federal grant | Department of Health and Human Services · Phase I · Fibrinogen coated albumin spheres to accelerate bone healing in older adults. | $246,634 | |
| Federal grant | Department of Health and Human Services · Phase I · Fibrinogen coated albumin spheres to accelerate bone healing in older adults. | $246,634 | |
| Federal grant | Department of Health and Human Services · Phase I · Fibrinogen-coated albumin nanospheres for mitigation of irradiation-induced wound healing impairment in breast cancer patients. | $386,470 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1273 | Beam Therapeutics | — | $180M |
| 1274 | SYNSPIRA THERAPEUTICS, INC. | — | — |
| 1275 | NANOTHERAPEUTICS, INC. | — | — |
| 1276 | FIBROPLATE INC | — | — |
| 1277 | Purine Pharmaceuticals Inc. | — | — |
| 1278 | EDITPEP INC | — | $8.2M |
| 1279 | DNATWO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.